NL2014402B1 - Tailored nano-meso particles. - Google Patents
Tailored nano-meso particles. Download PDFInfo
- Publication number
- NL2014402B1 NL2014402B1 NL2014402A NL2014402A NL2014402B1 NL 2014402 B1 NL2014402 B1 NL 2014402B1 NL 2014402 A NL2014402 A NL 2014402A NL 2014402 A NL2014402 A NL 2014402A NL 2014402 B1 NL2014402 B1 NL 2014402B1
- Authority
- NL
- Netherlands
- Prior art keywords
- particles
- nozzle
- nozzles
- collector
- foregoing
- Prior art date
Links
- 239000002245 particle Substances 0.000 title claims abstract description 80
- 238000000034 method Methods 0.000 claims abstract description 26
- 238000005507 spraying Methods 0.000 claims abstract description 12
- 239000007788 liquid Substances 0.000 claims description 12
- 239000000463 material Substances 0.000 claims description 12
- 239000012530 fluid Substances 0.000 claims description 11
- 239000003814 drug Substances 0.000 claims description 8
- 230000005672 electromagnetic field Effects 0.000 claims description 6
- 239000004065 semiconductor Substances 0.000 claims description 6
- 239000003054 catalyst Substances 0.000 claims description 5
- 239000011248 coating agent Substances 0.000 claims description 5
- 238000000576 coating method Methods 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 230000002209 hydrophobic effect Effects 0.000 claims description 4
- 102000004190 Enzymes Human genes 0.000 claims description 3
- 108090000790 Enzymes Proteins 0.000 claims description 3
- 239000003446 ligand Substances 0.000 claims description 3
- 238000005086 pumping Methods 0.000 claims description 3
- 229940079593 drug Drugs 0.000 claims description 2
- 238000004891 communication Methods 0.000 claims 1
- 238000007787 electrohydrodynamic spraying Methods 0.000 abstract description 13
- 238000011109 contamination Methods 0.000 abstract description 6
- 241001354243 Corona Species 0.000 description 35
- 239000007921 spray Substances 0.000 description 12
- 238000009987 spinning Methods 0.000 description 8
- 238000000151 deposition Methods 0.000 description 7
- 230000008021 deposition Effects 0.000 description 7
- 238000013459 approach Methods 0.000 description 6
- 238000001704 evaporation Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 239000004020 conductor Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000004992 fission Effects 0.000 description 5
- 239000007789 gas Substances 0.000 description 5
- -1 opiates Substances 0.000 description 5
- 239000002243 precursor Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 239000010409 thin film Substances 0.000 description 5
- NLVFBUXFDBBNBW-PBSUHMDJSA-N tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 description 5
- 229960000707 tobramycin Drugs 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 230000015556 catabolic process Effects 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 230000008020 evaporation Effects 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 230000005684 electric field Effects 0.000 description 3
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 3
- 239000010408 film Substances 0.000 description 3
- 239000011540 sensing material Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 108010078777 Colistin Proteins 0.000 description 2
- 201000003883 Cystic fibrosis Diseases 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- 238000000889 atomisation Methods 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229960003346 colistin Drugs 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- PJMPHNIQZUBGLI-UHFFFAOYSA-N fentanyl Chemical group C=1C=CC=CC=1N(C(=O)CC)C(CC1)CCN1CCC1=CC=CC=C1 PJMPHNIQZUBGLI-UHFFFAOYSA-N 0.000 description 2
- 229960002428 fentanyl Drugs 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 238000005227 gel permeation chromatography Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- JORAUNFTUVJTNG-BSTBCYLQSA-N n-[(2s)-4-amino-1-[[(2s,3r)-1-[[(2s)-4-amino-1-oxo-1-[[(3s,6s,9s,12s,15r,18s,21s)-6,9,18-tris(2-aminoethyl)-3-[(1r)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-h Chemical compound CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O JORAUNFTUVJTNG-BSTBCYLQSA-N 0.000 description 2
- XDJYMJULXQKGMM-UHFFFAOYSA-N polymyxin E1 Natural products CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCN)NC1=O XDJYMJULXQKGMM-UHFFFAOYSA-N 0.000 description 2
- KNIWPHSUTGNZST-UHFFFAOYSA-N polymyxin E2 Natural products CC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCN)NC1=O KNIWPHSUTGNZST-UHFFFAOYSA-N 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 2
- 229910052721 tungsten Inorganic materials 0.000 description 2
- 239000010937 tungsten Substances 0.000 description 2
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- PZSMUPGANZGPBF-UHFFFAOYSA-N 4-[5-(dithiolan-3-yl)pentanoylamino]butanoic acid Chemical compound OC(=O)CCCNC(=O)CCCCC1CCSS1 PZSMUPGANZGPBF-UHFFFAOYSA-N 0.000 description 1
- 229930000680 A04AD01 - Scopolamine Natural products 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 208000000003 Breakthrough pain Diseases 0.000 description 1
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 description 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
- 206010021133 Hypoventilation Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 102000015933 Rim-like Human genes 0.000 description 1
- 108050004199 Rim-like Proteins 0.000 description 1
- GIIZNNXWQWCKIB-UHFFFAOYSA-N Serevent Chemical compound C1=C(O)C(CO)=CC(C(O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1 GIIZNNXWQWCKIB-UHFFFAOYSA-N 0.000 description 1
- QJJXYPPXXYFBGM-LFZNUXCKSA-N Tacrolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1\C=C(/C)[C@@H]1[C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]([C@H](C[C@H]2C)OC)O[C@@]2(O)C(=O)C(=O)N2CCCC[C@H]2C(=O)O1 QJJXYPPXXYFBGM-LFZNUXCKSA-N 0.000 description 1
- BWKQDFQFEBGOQJ-NKBQLWGUSA-N [(2E,6E)-9-[(2R)-3,3-dimethyloxiran-2-yl]-3,7-dimethylnona-2,6-dienyl] 2-diazoacetate Chemical compound C\C(CC\C=C(/C)CC[C@H]1OC1(C)C)=C/COC(=O)C=[N+]=[N-] BWKQDFQFEBGOQJ-NKBQLWGUSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940065524 anticholinergics inhalants for obstructive airway diseases Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000012300 argon atmosphere Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 229960004436 budesonide Drugs 0.000 description 1
- 229930003827 cannabinoid Natural products 0.000 description 1
- 239000003557 cannabinoid Substances 0.000 description 1
- 229940065144 cannabinoids Drugs 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000011258 core-shell material Substances 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229960004242 dronabinol Drugs 0.000 description 1
- 230000003670 easy-to-clean Effects 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000004110 electrostatic spray deposition (ESD) technique Methods 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 229960002714 fluticasone Drugs 0.000 description 1
- MGNNYOODZCAHBA-GQKYHHCASA-N fluticasone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(O)[C@@]2(C)C[C@@H]1O MGNNYOODZCAHBA-GQKYHHCASA-N 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- MFWNKCLOYSRHCJ-BTTYYORXSA-N granisetron Chemical compound C1=CC=C2C(C(=O)N[C@H]3C[C@H]4CCC[C@@H](C3)N4C)=NN(C)C2=C1 MFWNKCLOYSRHCJ-BTTYYORXSA-N 0.000 description 1
- 229960003727 granisetron Drugs 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 238000001794 hormone therapy Methods 0.000 description 1
- 208000000122 hyperventilation Diseases 0.000 description 1
- HIFJCPQKFCZDDL-ACWOEMLNSA-N iloprost Chemical compound C1\C(=C/CCCC(O)=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)C(C)CC#CC)[C@H](O)C[C@@H]21 HIFJCPQKFCZDDL-ACWOEMLNSA-N 0.000 description 1
- 229960002240 iloprost Drugs 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229940125389 long-acting beta agonist Drugs 0.000 description 1
- 240000004308 marijuana Species 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 201000006417 multiple sclerosis Diseases 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 230000003533 narcotic effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 230000000771 oncological effect Effects 0.000 description 1
- 229940127240 opiate Drugs 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000002638 palliative care Methods 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- JZCPYUJPEARBJL-UHFFFAOYSA-N rimonabant Chemical compound CC=1C(C(=O)NN2CCCCC2)=NN(C=2C(=CC(Cl)=CC=2)Cl)C=1C1=CC=C(Cl)C=C1 JZCPYUJPEARBJL-UHFFFAOYSA-N 0.000 description 1
- 229960003015 rimonabant Drugs 0.000 description 1
- 229960004017 salmeterol Drugs 0.000 description 1
- 238000001878 scanning electron micrograph Methods 0.000 description 1
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
- 229960002646 scopolamine Drugs 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000000935 solvent evaporation Methods 0.000 description 1
- 238000001370 static light scattering Methods 0.000 description 1
- 230000003746 surface roughness Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000009121 systemic therapy Methods 0.000 description 1
- 229960001967 tacrolimus Drugs 0.000 description 1
- QJJXYPPXXYFBGM-SHYZHZOCSA-N tacrolimus Natural products CO[C@H]1C[C@H](CC[C@@H]1O)C=C(C)[C@H]2OC(=O)[C@H]3CCCCN3C(=O)C(=O)[C@@]4(O)O[C@@H]([C@H](C[C@H]4C)OC)[C@@H](C[C@H](C)CC(=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)C)OC QJJXYPPXXYFBGM-SHYZHZOCSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- LERNTVKEWCAPOY-DZZGSBJMSA-N tiotropium Chemical compound O([C@H]1C[C@@H]2[N+]([C@H](C1)[C@@H]1[C@H]2O1)(C)C)C(=O)C(O)(C=1SC=CC=1)C1=CC=CS1 LERNTVKEWCAPOY-DZZGSBJMSA-N 0.000 description 1
- 229940110309 tiotropium Drugs 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 238000007704 wet chemistry method Methods 0.000 description 1
- UTAZCRNOSWWEFR-ZDUSSCGKSA-N zolmitriptan Chemical compound C=1[C]2C(CCN(C)C)=CN=C2C=CC=1C[C@H]1COC(=O)N1 UTAZCRNOSWWEFR-ZDUSSCGKSA-N 0.000 description 1
- 229960001360 zolmitriptan Drugs 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B5/00—Electrostatic spraying apparatus; Spraying apparatus with means for charging the spray electrically; Apparatus for spraying liquids or other fluent materials by other electric means
- B05B5/16—Arrangements for supplying liquids or other fluent material
- B05B5/1608—Arrangements for supplying liquids or other fluent material the liquid or other fluent material being electrically conductive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
- A61M11/001—Particle size control
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/02—Inhalators with activated or ionised fluids, e.g. electrohydrodynamic [EHD] or electrostatic devices; Ozone-inhalators with radioactive tagged particles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B5/00—Electrostatic spraying apparatus; Spraying apparatus with means for charging the spray electrically; Apparatus for spraying liquids or other fluent materials by other electric means
- B05B5/025—Discharge apparatus, e.g. electrostatic spray guns
- B05B5/0255—Discharge apparatus, e.g. electrostatic spray guns spraying and depositing by electrostatic forces only
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B5/00—Electrostatic spraying apparatus; Spraying apparatus with means for charging the spray electrically; Apparatus for spraying liquids or other fluent materials by other electric means
- B05B5/025—Discharge apparatus, e.g. electrostatic spray guns
- B05B5/035—Discharge apparatus, e.g. electrostatic spray guns characterised by gasless spraying, e.g. electrostatically assisted airless spraying
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B5/00—Electrostatic spraying apparatus; Spraying apparatus with means for charging the spray electrically; Apparatus for spraying liquids or other fluent materials by other electric means
- B05B5/025—Discharge apparatus, e.g. electrostatic spray guns
- B05B5/053—Arrangements for supplying power, e.g. charging power
- B05B5/0533—Electrodes specially adapted therefor; Arrangements of electrodes
- B05B5/0536—Dimensional characteristics of electrodes, e.g. diameter or radius of curvature of a needle-like corona electrode
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2206/00—Characteristics of a physical parameter; associated device therefor
- A61M2206/10—Flow characteristics
- A61M2206/18—Coaxial flows, e.g. one flow within another
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B5/00—Electrostatic spraying apparatus; Spraying apparatus with means for charging the spray electrically; Apparatus for spraying liquids or other fluent materials by other electric means
- B05B5/001—Electrostatic spraying apparatus; Spraying apparatus with means for charging the spray electrically; Apparatus for spraying liquids or other fluent materials by other electric means incorporating means for heating or cooling, e.g. the material to be sprayed
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Electrostatic Spraying Apparatus (AREA)
- Application Of Or Painting With Fluid Materials (AREA)
Abstract
The present invention is in the field of electrospraying, and relates to a novel device and method for spraying, as well as particles obtained and use of said particles. By the present method and device characteristics of the particles can be adapted in a controlled and reliable manner and further contamination of the particles obtained is virtu ally absent.
Description
Title: Tailored nano-meso particles
FIELD OF THE INVENTION
The present invention is in the field of electrospraying, and relates to a novel device and method for spraying, as well as particles obtained and use of said particles. By the present method and device characteristics of the particles can be adapted in a controlled and reliable manner and further contamination of the particles obtained is virtually absent.
BACKGROUND OF THE INVENTION
Electrospraying (or electro hydrodynamic atomization, EHDA) relates to a process wherein e.g. a liquid is distributed into size-distributed droplets under the influence of an electrical field. From a reservoir or the like a liquid is transported to a nozzle. The nozzle is typically coupled to a high voltage source. To apply an electrical potential and moving charged particles in an electrical field a counter electrode is provided at some distance of the nozzle electrode. By creating a high voltage between the nozzle and the counter electrode due to the electrical forces and depending on the conductivity, surface tension and viscosity of the liquid at some threshold potential, a jet forms at the tip of the nozzle that later breaks up into charged liquid droplets; therewith a spray of droplets and in a later stage particles is formed.
The process is known to provide a spray of typically uniformly sized particles, which find application in aerosol delivery of e.g. a medicament.
It is considered that under evaporating condition, the initial electrosprayed droplet may go under so-called Coulomb fission if the Rayleigh limit of the charge density is reached. This is found to result in a breakdown of the initial droplet into small droplets; this increases a polydispersity of final products. Coulomb fission is found to be caused by an increase in charge density (reaching Rayleigh limit) as the volume of a droplet is decreasing due to evaporation. As an example of this effect, it is noted that thin films produced by Electrostatic Sprayed Deposition (ESD) have nanometer-size structures despite that the size of the initial sprayed drop lets is typically a few tens of microns in diameter. In physical and organic chemistry, the dispersity is a measure of the heterogeneity of sizes of molecules or particles in a mixture. A collection of objects is called monodisperse or uniform if the objects have the same size, shape, or mass. A sample of objects that have an inconsistent size, shape and mass distribution is called poly-disperse or non-uniform. The objects can be in any form of chemical dispersion, such as particles in a colloid, and polymer molecules in a solvent. Polymers can possess a distribution of molecular mass; and particles often possess a wide distribution of size, surface area and mass.
The term dispersity, represented by the symbol D, can refer to either molecular mass or degree of polymerization. It can be calculated using the equation DM = Mw/Mn, where Mw is the weight-average molar mass and Mn is the number-average molar mass.
The Mw is
calculated as follows: wherein Ni is the number of molecules of molecular mass Mi.
The mass average molecular mass is determined by static light scattering on a Brookhaven 90Plus.
The number average molar mass Mn is determined by measuring the molecular mass of n polymer molecules, summing the masses, and dividing hu n.
The number average molecular mass of a polymer is deter-mined by gel permeation chromatography, in particular by a Waters GPC using a Styragel column.
In electricity a corona discharge is an electrical discharge brought on by the ionization of a fluid surrounding a conductor that is electrically energized. The discharge will typically occur if the electric field strength around the conductor is high enough to form a conductive region, but not high enough to cause electrical breakdown or arcing to nearby obj ects.
Corona discharge may be introduced to electrospray to discharge charged droplets and avoid Coulomb fission. It should however be taken into account that corona discharge is found to be capable of creating ionic wind. Application of ionic winds is considered of great interest as a tool to regulate heat in electronics instead of using bulky mechanical fans. It has been found that the efficiency not high it can still be applied in a compact area with the least energy.
Various prior art systems may be mentioned in particular, such as the ones disclosed in NL2006794C and NL2008056C, of which the disclosures are incorporated by reference.
Despite advances in the past it still is difficult to adapt characteristics of particles, and droplets with the prior art systems in a controlled manner, and some characteristics can not be adapted at all. Also the prior art systems are prone to contamination of final particles obtained. Further challenges facing application of the electrospraying technique relate to a limitation in flow rate, uncontrolled characteristics of liquids (e.g. surface tension, conductivity) and Coulomb fission due to solvent evaporation. Further, a selective deposition in e.g. semiconductors is found to cause charge accumulation on deposited film, and as a result a limitation in feasible film thickness.
Therefore there still is a need for an improved electrospraying device, which overcomes one or more of the above disadvantages, without jeopardizing functionality and advantages .
SUMMARY OF THE INVENTION
The present invention relates in a first aspect to an electrospraying device according to claim 1, in a second aspect to a method of operating the present device according to claim 11, in a third aspect to a particle obtainable by the present device c.q. method according to claim 13, and in a fourth aspect to an inhale or particle delivery system according to claim 15.
The present inventors introduce an innovative idea that applies ionic winds produced by multiple coronas along the electrospray nozzles in a turbulence-like mode. The ionic wind relates to an airflow induced by electrostatic forces linked to corona discharge arising at the tips of some sharp conductors subjected to high voltage relative to ground. The coronas are preferably from a conducting material and have sharp tips, such as needles. Preferably very thin tips are used, such as having a cross-section of less than 1 mm, preferably less than 0.5 mm, such as less than 0.2 mm. The turbulence mode may be increased by a means for varying an electro-magnetic field. For instance the potential of the coronas may be varied, such as in a repetitive manner, having a certain frequency (e.g. 50-10.000 kHz), such as in a sinusoidal mode. There may also be a phase-difference between the corona, such as a phase difference of 2i/number of coronas, or a multitude or fraction thereof. Also a feedback loop may be provided, in order to further stabilize the multi jet spinning mode. Preferably a rotating (or spinning) ionic wind is created. This has found to create particles with a unique structure and characteristics that are not accessible with traditional bulk methods, such as the above mentioned. By the introduced method and device a metastable structure, of constantly drying droplets in the electrospray, is reserved for further processing. Important elements in this approach are the electrospraying configuration of the present device and an operational mode. Therein a residence time of a droplet-particle in the gas phase increases. The residence time can be controlled by neutralizing the droplet and/or size of the droplet-particle. One can tailor a final particle size (distribution) by adjusting one or more of a liquid flow rate of the liquid, the geometry and configuration of the nozzles, to control and direct the electrical wind and its strength, providing the particles with an extended and controllable residence time in the gas phase allowing them to shape as required, the option of freezing metastable structures (of meso- and nanoscale size) of especially metal oxides, and the charge on the particle by adjusting corona discharge parameters.
The present inventors modulate the charge density of the droplets by inducing an ionic wind along the spray. Using the Ionic wind assisted electrohydrodynamic atomization technique inventors explored various possibilities to reach a stable mode in terms of jet formation, spray quality and droplet-particle size and size distribution. By varying applied electrical potential and flow rate, inventors were able to electrospray different solutions. Inventors identified different regimes of jet formation and spraying modes. Inventors also explored the possibility to use multi-jet mode as a practical approach to produce particles with acceptable polydispersity. Using WO3 as a test material, inventors demonstrated how the ionic wind assisted electrospraying deposition (ESD) technique is used to tailor morphological properties of deposited porous thin film. Advantages are amongst others a multi-jet mode as a practical way to produce particles with defined final product characteristics, tailoring mesoscopic morphology of deposited porous thin film, and overcoming the above mentioned problems .
The elecrospraying configuration of the present device is considered not to relate to a classical configuration. An important difference is that the ground is positioned upwards such that the evaporating droplet experiences an airflow combined with ions of opposite charges. It has been found that as a result the droplet is neutralized, the initial size is reserved and there is no urge in reaching ground electrode or being deposited. The residence time of such neutral droplet-particle is found to increase and by applying heat along the electrospraying pathway it is found that one can also manipulate the kinetics of drying. It is found that the required turbulence-like condition of the sprayed droplets is only possible if electrospraying in the present device takes place by a spinning mode, preferably a multi-jet mode. Spinning multi-jet mode is found to be a stable and reproducible mode that can be described as a combination of multi-jet and precession mode, which is found only accessible in presence of so-called ionic winds.
For sake of comparison it is noted that particles with different morphology and porosity can be synthesized by prior art methods by changing a chemical composition (such as mixing ratio) and synthesizing conditions. It has been found that the collected final particles of the same chemical composition produced by the present device can have a different size and porosity, which is found to depend on e.g. the flow rate and heat applied. This present and novel approach provides one with the opportunity to collect particles having adaptable characteristics, such as a similar chemical composition, without (measurable) contamination, and with different porosity, in a one-step approach; the nature of the present device and technique has as a result that contamination is virtually absent . Moreover it has been found that the present method provides the opportunities to produce nano-meso scale crystals and particles with unique structures that are not accessible with prior art wet chemistry methods.
It has been found that the present ionic wind assisted electrospray can be used to produce individual particles with a particular morphology, porosity and even further to produce nanoscale-mesoscale crystals. This is e.g. achieved by increasing the residence time of the drop-let/particles in the gas phase and at the same time providing a heat gradient. It has been found that the turbulencelike mode of spinning, which is found to be only accessible in the presence of ionic winds, as a tool to tune the drop-let/particle residence time, charge density and to create particles of any desired size with tailored morphology and porosity. Increasing the residence time of constantly drying droplet in gas phase in a random flow at which the droplet is balancing the surface tension and the imposed electrical forces will results in such unique nano-micro (meso) structures that cannot be achieved in bulk methods.
The present device comprises a container for maintaining a solution. The solution may be kept at a pressure of 10±1 kPa, i.e. about atmospheric. The container typically has a volume of 100 pl-20 ml, such as 0.001-1 ml; larger and smaller sizes are in principle possible, depending on a final design of the device. The solution, which may also be referred to as a pre-cursor solution for forming particles or the like, or likewise any fluid, suspension, solution, colloidal system, and biological system, may on application be transferred to the nozzles, typically through a tube or the like. It is noted that not only multi nozzles can be used, but also co-axial nozzles, having two liquids/fluids or more, supplied by e.g. two container or more, can be de livered and the final product will have a multi core-shell like structure. The present spraying mode is referred to as spinning multi jet because a multi jet stream mode is obtained having more than one jet streams, indicating that instead of one cone configurations that have as a result a single jet (stream) coming out of one nozzle there are more than one jet streams provided by the at least one nozzle and the induced ionic wind and possibility the ionic shielding gives a rotating effect as can be seen in figure 1-b, the last image thereof. At least two coronas are found to be required to create such an effect. It is noted that no physical component in the present device itself is rotating, The device comprises at least one nozzle, having an inside diameter and a length preferably providing capillary force, in fluid connection with the container, and wherein the at least one nozzle is preferably directed towards the collector at an angle of 90120 degrees, i.e. at a small angle deviating from perpendicular to perpendicular (with respect to a surface of the collector). The nozzle may be a coaxial nozzle. Also a potential may be applied to an inside of the nozzle, to an outside, or a combination thereof. Also a pump for pumping the solution from the container to the at least one nozzle is present. As typically amounts of fluid are very small, e.g. flow rates of 0.01 pl/s-1 ml/s, a pump may be very small as well. However there are no limitation and larger values can be adopted.
In order to form an electrospray at least one means for applying a maximum voltage of at least 1 kV to the nozzles is provided. The at least one means, or a second means, also provides a maximum voltage of at least 1 kV to the at least two coronas. The coronas may have a hydro-phobic coating, leaving a tip section uncoated. Further a collector is present for collecting or directing the spray and particles therein or formed thereof, the collector being electrically grounded and located in a spray direction and at a distance of less than 5 cm of the at least one nozzle. The distance can be 0 mm, that is the collector being at the same height as the nozzles. A material of the collector, such as a collecting plate, can be chosen from a wide variety of materials, including metals, semiconducting materials, plastics, coated materials, etc. The collector is for collecting in principle neutralized particles. It may be of a conductive material, and it may be grounded. To illustrate the amount of freedom in selecting a suitable material it is noted that the particles can be collected even on a tissue being waved at the direction of spray at a distance that should be the end of the spraying zone, or far enough that the droplets already dried out to particles or released from the turbulence flow. How far from the nozzles the collection area is depends e.g. on the solution used and temperature applied. At least two coronas are provided being located around the nozzles, preferably at a substantial similar height as the nozzles, and the structure being electrically grounded. There may be one conducting structure per nozzle, a combined structure for all nozzles being present, or a partly combined structure and a structure for the at least one nozzle. Also at least two coronas is provided, the at least two coronas located around the at least one nozzle and around the conducting structure, preferably at a substantial similar height as the nozzles. Typically at least two coronas are provided for the combined nozzles. As with the conducting structure, also coronas may be combined.
Thereby the present invention provides a solution to one or more of the above mentioned problems.
Advantages of the present invention are detailed throughout the description.
DETAILED DESCRIPTION OF THE INVENTION
The present invention relates in a first aspect to a device according to claim 1.
In an exemplary embodiment the present device comprises a heat provider for heating the collector.
In an exemplary embodiment of the present device the at least one means for applying a voltage is capable of applying to the corona a voltage opposite of the voltage applied to the nozzles, e.g. the corona having a positive voltage and the nozzles having a negative voltage, or vice versa .
In an exemplary embodiment of the present device the nozzles has an inside diameter of <500 pm, preferably 1-250 pm, more preferably 2-100 pm, even more preferably 5-75 pm, such as preferably 10-60 pm, and wherein the distance is 0.1mm-10 mm, preferably 0.2mm-5mm, more preferably 0.3mm-2mm, such as 0.5-1 mm. In an example a gauge 30 needle is used.
In an exemplary embodiment of the present device the nozzles has a length of 1-10 mm. The above dimensions provide optimal results in terms of amount of solution sprayed versus amounts of particles obtained, electrical voltage and current applied, power consumption (pW-mW), etc .
In an exemplary embodiment of the present device the nozzles has a removable or breakable sealing. Such is especially advantageous when the present device is used for spraying of constituents which are vulnerable to degradation and/or contamination, such as in the case of medicaments .
In an exemplary embodiment of the present device the collector provides a solid surface, or is partly mesh shaped.
In an exemplary embodiment of the present device the at least one means for applying a voltage provides a current of 1 nA-lpA, therewith reducing power consumption, preventing risk of degradation, etc.
In an exemplary embodiment of the present device the at least one means for applying a voltage provides a high frequency pulsed electro-magnetic field, such as from 100 Hz-100 kHz, preferably 1 kHz-10kHz. Therewith spraying is improved, e.g. in terms of efficiency.
In an exemplary embodiment of the present device the at least one nozzle comprises an outer hydrophobic coating, which coating covers the nozzle typically partially. Such is especially relevant if the fluid/solution uses water or another hydrophilic solvent, such as an alcohol. The spray-pattern and flow are further improved hereby.
In a second aspect the present invention relates to a method according to claim 11, comprising the steps of atomizing and charging liquid particles, spraying the particles and collecting the particles.
In an exemplary embodiment of the present method the collector is moved over time in a direction perpendicular to the spray direction. Therewith an even distribution of particles over a collector surface can be obtained.
In a third aspect the present invention relates to particles according to claim 13, obtainable by the present method and/or with the present device.
In an exemplary embodiment of the present particles they are selected from a biological particle selected from the group consisting of an enzyme, a receptor and a ligand, and a medicament, a catalyst, a semiconductor material, and a sensing material. The medicament can be a for treating respiratory problems, lung diseases, such as COPD, hyper- or hypoventilation, cystic fibrosis, asthma, breakthrough cancer pain, pain in general, diabetes, wound care, vaccination in general, antiviral application, antibiotic application, hormone therapy, narcotic analgesics, influenza treatment, anaphylaxis treatment, multiple sclerosis treatment, acute migraine, etc. The present system can be further adapted in such a way that it provides a delivery of a low dosage (ρΐ-μΐ), having advantages such as no or limited side effects, being aseptic, having a mono-disperse particle size distribution (e.g. in the pm range, e.g. 2-5 pm), acute treatment, fast effect (within 7-10 seconds), short time of application, easy to use, such as a handheld design, wireless connectivity, easy to clean, durable, comprising a separate drug container. Examples of medicaments relate to corticosteroids, opiates, cannabinoids, LABA's, agonists, antagonists, hormones, such as estrogens, anticholinergics, peptides, synthetic or natural analogues, Na+ channel blockers, such as fluticasone, salmeterol, fenta-nyl, Δβ-THC, zolmitriptan, granisetron, rimonabant, estradiol, scopolamine, teriparitide, budesonide, iloprost, li-docaine, insulin, tiotropium Br, colistin, dornase, liposomal antifungals, and tacrolimus. Molecules obtained are typically relatively small, such as less than 10 kDa, preferably < 6 kDa, such as <lkDa. The catalyst particles can be made extremely pure, which is considered a big advantage for catalyst, and also a size, porosity, morphology, and composition can be tuned precisely. Such advantages are also found in sensing materials, such as T1O2, and semiconductor materials. A typical dosage (e.g. tobramycin) of 1-10 mg, in e.g. 0.01-1 ml of solvent (e.g. 70% water and 30% ethanol).
In a fourth aspect the present invention relates to an inhale or particle delivery system according to claim 15, comprising the present device.
In an exemplary embodiment the inhaler or system further comprises an inhaler mask.
The invention is further detailed by the accompanying figures and examples, which are exemplary and explanatory of nature and are not limiting the scope of the invention. To the person skilled in the art it may be clear that many variants, being obvious or not, may be conceivable falling within the scope of protection, defined by the present claims.
SUMMARY OF FIGURES
Figure la. Example of present device, lb: spray patterns .
Figure 2. SEM pictures of a collector with particle, (a) prior art and (b) present invention.
Fig. 3 shows schematics of a nozzle.
Fig. 4 shows a multi-nozzle multi-corona layout.
Fig. 5 shows SEM pictures of tobramycin.
DETAILED DESCRIPTION OF FIGURES
In the figures: 1: dispensing liquid unit; 2: tubing; 3: electrospraying nozzle; 4: corona needles; 5: Grounded ring; 6: heated substrate, which can be extended to be like a tube around the whole unit.
Figure la. Example of present device, lb: spray patterns. In the present device a container 1 with a precursor solution (solution, colloidal suspension) or fluid is provided, typically having a pump for displacing the fluid. The container is in fluid connection with the at least one nozzle 3 by a tubing 2 or the like. Through the nozzles the precursor solution is sprayed. Around the nozzles coronas, such as needles, wires, a tooth-like conducting object, are provided, typical two or more, such as 3-10. Typically these corona elements are evenly distributed around the nozzles, such as at a relative angle (around a virtual circle) of 360/n degrees, n being the number of coronas. In addition a grounded element 5, such as a ring is provided. For collecting a collection substrate 6 is provided, which may be heated. The collector may be extended upwards towards the nozzles and even surround the whole device.
Figure 2. SEM pictures of a collector with particle, (a) prior art and (b) present invention. Fig. 2a shows particles that have a preferential deposition. The solvent of the solution evaporates mainly (80% or more thereof) before deposition takes place, whereas the remainder evaporates later. Particles are as a result typically stacked along rim-like structures, as is schematically indicated in the drawing at the right of fig. 2a. With the present device (see fig. 2b) evaporation of solvent takes place largely before deposition. The surface roughness is different and depends on the kinetics of drying, which can be adapted via parameters such as flow rate, temperature and ionic wind. Coulomb fission is avoided and the residence time of droplets and particles in gas phase is increased, as is schematically indicated in the drawing at the right of fig. 2b. The circles show relatively large and uniform particles, evenly distributed over the collecting surface, and no rims.
Fig. 3 shows schematics of a nozzle. In fig. 3a the high voltage is applied to an internal part of the nozzle, in fig. 3b to an external part. Fig. 3c shows 3 nozzles directed in slightly different orientations.
Fig. 4 shows a cross-section of a multi-nozzle multicorona layout. Therein 3 nozzles 3, a grounded ring 5, and six coronas 4 are shown.
Fig. 5 shows SEM pictures of tobramycin. 80 mg/ml to- bramycin was applied in a 50:50 water: ethanol solution. In fig. 5a a prior art cone jet with 2.5 ml/h was used, in fig. 5b a multi jet also wit 2.5 ml/h. The present system clearly performs better.
The figures are further detailed in the description of the experiments below.
EXAMPLES/EXPERIMENTS
The invention although described in detailed explanatory context may be best understood in conjunction with the accompanying examples and figures.
As far as materials used, the spinning multi jet stream mode was observed with a range of ethanol-water mixture with weight ratio of (100:0 to 50:50). The relative distance of corona to ground ring, nozzles to ground ring and be changed in a range of dimension. For example: the coronas and grounded ring and nozzles are at the same level, the coronas are above the ring-nozzles and below the grounded ring, the coronas are above the ring-nozzles and above the grounded ring, and the coronas are below the ring-nozzles and above the grounded ring.
Using WO3 as a test material inventors further demonstrate how the particles are produced in the present electrospraying mode. The exemplary set up consisted of a syringe pump, an electrospray nozzle (0.25 mm internal diameter (ID), 0.52 mm outer diameter (OD)) surrounded by 12 corona needles, a grounded ring and a heated collection plate. The distances between (1) the nozzles and the grounded ring, (2) the corona and the ground electrode, and (3) the nozzles and the heating plate were 6, 2 and 20 mm, respectively. A tungsten precursor solution was prepared as described by Gaury et al.[Gaury, J.; Kelder, E. M.; Bychkov, E.; Biskos, G., Characterization of Nb-doped WO3 thin films produced by Electrostatic Spray Deposition. Thin Solid Films 2013, 534, 32-39.]: i.e., 5 ml of W(ipr)6 were mixed with 50 ml of 2-propanol under argon atmosphere. The as-prepared precursor solution was then pumped through the electrospray nozzles at flow rates ranging from 0.5 to 10 ml/h. Evaporation of the droplet and oxidation of tungsten occurred during the evaporation stage (ES0, resulted in pure WO3 nanoparticles, having a median size of 8 nm.
The resulting particles were deposited on alumina (AI2O3) substrates placed on top of the heating plate that was maintained between 300 and 310 °C. The duration of all the depositions was 10 min. The morphological properties of the resulting thin film samples were studied using a Scanning Electron Microscope (SEM; Jeol JSM-6010LA). All samples were coated by a thin layer of gold to avoid surface charge disturbances during the measurements. The figure provided as fig. 2-b is for a flow rate of 5 ml/hr.
In an example an antibiotic, specifically tobramycin in ethanol-water solution (10-80 mg/ml in ethanol-water with volume ration of about (80:20) to (50:50), was investigated, uniform particles as evidenced by SEM images was collected in the spinning multi jet mode. Tobramycin is of importance for treating cystic fibrosis.
The possibility of delivery of particles of 1-5 micrometer with a narrow size distribution in short time is found to be an effective treatment.
In a similar approach 6 mg colistin and 7.8 mg dor-nase was administered.
In another comparable approach for systemic therapy 5.4 mg fentanyl, and 8.9 mg cannabis were administered twice per day, and in an example as palliative care in oncological inhaler therapy.
It should be appreciated that for commercial application it may be preferable to use one or more variations of the present system, which would similar be to the ones disclosed in the present application and are within the spirit of the invention.
For the sake of searching only the clauses have been provided below in English. 1. Device for electro-spraying comprising (a) a container for maintaining a solution, (b) at least one nozzle, having an inside diameter and a length, in fluid connection with the container, (c) a pump for pumping the solution from the container to the at least one nozzle, (d) an electrically conducting structure, the structure being located around the nozzle preferably at a substantial similar height as the nozzle, and the structure being electrically grounded, (e) a collector, the collector being electrically grounded and located in a spray direction and at a distance of less than 5 cm of the at least one nozzle, (f) at least two coronas, the at least two coronas located around the at least one nozzle and around the con-ducting structure, preferably at a substantial similar height as the nozzle, (g) at least one means for applying a maximum voltage of at least 1 kV to the nozzles and a maximum voltage of at least 1 kV to the at least two coronas, and (h) optionally a means for varying an electro-magnetic field. 2. Device according to claim 1, further comprising a heat provider for heating the collector. 3. Device according to any of the preceding claims, wherein the at least one means for applying a maximum voltage is capable of applying to the corona a voltage opposite of the voltage applied to the nozzles. 4. Device according to any of the preceding claims, wherein the at least one nozzle provide capillary force, and having an inside diameter of <500 pm, and wherein the distance is 0.1mm-10 mm. 5. Device according to any of the preceding claims, wherein the nozzles have a length of 1-10 mm. 6. Device according to any of the preceding claims, wherein the nozzles have a removable or breakable sealing. 7. Device according to any of the preceding claims, wherein the collector provides a solid surface, or is partly mesh shaped. 8. Device according to any of the preceding claims, wherein the at least one means for applying a voltage provides a current of 1 ηΑ-1μΑ. 9. Device according to any of the preceding claims, wherein the at least one means for applying a voltage provides a high frequency pulsed electro-magnetic field. 10. Device according to any of the preceding claims, wherein the nozzles comprise an outer hydrophobic coating. 11. Method of operating a device according to any of the preceding claims, comprising the steps of atomizing and charging liquid particles, spraying the particles and collecting the particles. 12. Method according to claim 10, wherein the collector is moved over time in a direction perpendicular to the spray direction. 13. Particles obtainable by the method according to any of claims 11-12. 14. Particles according to claim 13, wherein the particles are selected from a biological particle selected from the group consisting of an enzyme, a receptor and a ligand, and a medicament, a catalyst, a semiconductor material, and a sensing material. 15. Inhaler or particle delivery system comprising a device according to any of claims 1-10. 16. Inhaler or system according to claim 15, further comprising an inhaler mask.
Claims (16)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL2014402A NL2014402B1 (en) | 2015-03-05 | 2015-03-05 | Tailored nano-meso particles. |
| PCT/NL2016/050141 WO2016140570A1 (en) | 2015-03-05 | 2016-02-29 | Tailored micro-particles |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL2014402A NL2014402B1 (en) | 2015-03-05 | 2015-03-05 | Tailored nano-meso particles. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL2014402B1 true NL2014402B1 (en) | 2016-10-13 |
Family
ID=53189122
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL2014402A NL2014402B1 (en) | 2015-03-05 | 2015-03-05 | Tailored nano-meso particles. |
Country Status (2)
| Country | Link |
|---|---|
| NL (1) | NL2014402B1 (en) |
| WO (1) | WO2016140570A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018161071A1 (en) * | 2017-03-03 | 2018-09-07 | Idealchain, Llc | Facile encapsulation of dyes via air-controlled electrospray |
| RU2688586C1 (en) * | 2017-12-08 | 2019-05-21 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Саратовский национальный исследовательский государственный университет имени Н.Г. Чернышевского" | Device for coaxial electrohydrodynamic formation of polymer micro- or submicrone structures |
| CN109530158B (en) * | 2018-11-23 | 2020-11-03 | 大连理工大学 | An electric field-driven device and method for transferring trace amounts of high-viscosity glue |
| EP3760194A1 (en) | 2019-07-01 | 2021-01-06 | DBV Technologies | Method of depositing a substance on a substrate |
| CN110625924B (en) * | 2019-11-18 | 2022-04-01 | 西交利物浦大学 | Monitoring system of electrospray biological stent manufacturing device based on double digital electron microscope |
| CN113512718A (en) * | 2020-04-09 | 2021-10-19 | 中国科学院微电子研究所 | Vaporization device, thin film deposition equipment and method for vaporizing precursor in thin film deposition |
| CN112679631B (en) * | 2020-12-22 | 2022-07-08 | 宁波南大光电材料有限公司 | Method for removing small molecular substances in synthetic resin |
| CN114521481B (en) * | 2022-02-16 | 2023-08-29 | 江苏大学 | Atomization cultivation device and method |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1171243A1 (en) * | 1999-04-23 | 2002-01-16 | Battelle Memorial Institute | High mass transfer electrosprayer |
| US20110041840A1 (en) * | 2008-01-16 | 2011-02-24 | Boehringer Ingelheim International Gmbh | Atomizing Device, Inhaler and Method for Dispensing a Liquid Formulation |
| WO2013100766A1 (en) * | 2011-12-29 | 2013-07-04 | Gilbert Technologies B.V. | System and method for delivering sprayed particles by electrospraying |
| WO2014149695A1 (en) * | 2013-03-15 | 2014-09-25 | Applied Materials, Inc. | Apparatus for material spray deposition of high solid percentage slurries for battery active material manufacture applications |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6068198A (en) * | 1999-03-23 | 2000-05-30 | Gupta; Umesh | Aerosol generating and dispensing system |
| NL2006794C2 (en) | 2011-05-17 | 2012-11-20 | Univ Delft Tech | System for and method of delivering sprayed particles. |
-
2015
- 2015-03-05 NL NL2014402A patent/NL2014402B1/en not_active IP Right Cessation
-
2016
- 2016-02-29 WO PCT/NL2016/050141 patent/WO2016140570A1/en not_active Ceased
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1171243A1 (en) * | 1999-04-23 | 2002-01-16 | Battelle Memorial Institute | High mass transfer electrosprayer |
| US20110041840A1 (en) * | 2008-01-16 | 2011-02-24 | Boehringer Ingelheim International Gmbh | Atomizing Device, Inhaler and Method for Dispensing a Liquid Formulation |
| WO2013100766A1 (en) * | 2011-12-29 | 2013-07-04 | Gilbert Technologies B.V. | System and method for delivering sprayed particles by electrospraying |
| WO2014149695A1 (en) * | 2013-03-15 | 2014-09-25 | Applied Materials, Inc. | Apparatus for material spray deposition of high solid percentage slurries for battery active material manufacture applications |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2016140570A1 (en) | 2016-09-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL2014402B1 (en) | Tailored nano-meso particles. | |
| Zhang et al. | One-step preparation of chitosan solid nanoparticles by electrospray deposition | |
| US7193124B2 (en) | Method for forming material | |
| EP0912251B1 (en) | A dispensing device and method for forming material | |
| US7977527B2 (en) | Dispensing device and method for forming material | |
| US11311900B2 (en) | Methods and systems for creating aerosols | |
| Ijsebaert et al. | Electro-hydrodynamic atomization of drug solutions for inhalation purposes | |
| Ciach | Microencapsulation of drugs by electro-hydro-dynamic atomization | |
| EP2237773A1 (en) | Method for making patches by electrospray | |
| CN104549831B (en) | Generate the method and system of aerosol | |
| JP2011509785A5 (en) | ||
| Zhang et al. | Direct observation and characterization of the generation of organic solvent droplets with and without triglyceride oil by electrospraying | |
| Deotare et al. | Fabrication of silica nanocomposite-cups using electrospraying | |
| DK2411136T3 (en) | METHOD AND APPARATUS FOR THE MANUFACTURE OF coated particles | |
| ES2308154T3 (en) | POWDER GENERATOR AND METHOD TO PRODUCE POWDER. | |
| Wang et al. | Electrospray of core–shell micro drug carriers with various experimental and material parameters | |
| Grafahrend et al. | Development and optimization of an electrospraying device for the continuous collection of nano-and microparticles | |
| US20190015338A1 (en) | Preparation apparatus for nanocomposite material and self-assembly preparation method | |
| Martin-Banderas et al. | Use of Flow Focusing® technology to produce tobramycin-loaded PLGA microparticles for pulmonary drug delivery | |
| Nyström et al. | Processing of pharmaceutical materials by electrospraying under reduced pressure | |
| JP2015115462A (en) | Coating apparatus and coating method | |
| Seong et al. | Deposition of controllable nanoparticles by hybrid aerodynamic and electrostatic spray | |
| JP2022542785A (en) | METHOD OF DEPOSITING A SUBSTRATE ON A SUBSTRATE | |
| Doan et al. | Particle self-neutralization for highly efficient deep lung drug delivery via bipolar electrohydrodynamic atomization | |
| Vu et al. | Electrohydrodynamic Nebuliser (eNEB) for Direct Pulmonary Drug Delivery Application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Lapsed because of non-payment of the annual fee |
Effective date: 20180401 |